Silo Wellness and Entheon Biomedical’s Wholly-Owned Subsidiary, HaluGen Life Sciences, Announces Psychedelics Genetic Test Kit Partnership

NEXT STORY
Insights on the Microfluidics Global Market to 2029 – Key Drivers, Challenges and Opportunities
PREV STORY
Worldwide AI in Healthcare Industry to 2026 – Competitive Analysis and the Impact of COVID-19
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

ICU Medical, Inc. Announces Time of Fourth Quarter and Fiscal Year 2015 Earnings Call

SAN CLEMENTE, Calif., Jan. 22, 2016 (GLOBE NEWSWIRE) -- ICU Medical, Inc., (Nasdaq:ICUI), a ...

author_avatar
NASDAQ Market News

RedHill Biopharma Announces Completion of Enrollment for Confirmatory Phase III Study with TALICIA® for H. pylori Infection

Top-line results from the randomized, double-blind confirmatory Phase III study (ERADICATE Hp2 study) with ...

author_avatar
NASDAQ Market News

Cue Biopharma and LG Chem Life Sciences Announce WT1 as the Next Immuno-STAT™ Target in Oncology

   WT1 is a Well-Characterized Oncofetal Antigen, Expressed in Solid Tumors and Hematologic Malignancies CAMBRIDGE, Mass., ...

author_avatar
NASDAQ Market News